Subsequent studies found that overexpression of CBR3-AS1 was observed in gastric carcinoma, esophageal squamous cell carcinoma, osteosarcoma, colorectal cancer and retinoblastoma [17–21]. This evidence concerns the gene CBR3 and retinoblastoma.